Drug intelligence / Profile preview

Bacto

Development stage: Unknown
Lead developer: Quality Pharm
Modality: Small Molecules

Overview

Bacto is a branded generic pharmaceutical product marketed by Quality Pharma (Quality Pharma Products Pvt. Ltd.), an Indian pharmaceutical company based in Assam. It is part of Quality Pharma's portfolio of marketed generic formulations across various medical specialties. As a branded generic, it is approved and commercially available in India, though specific details regarding its active pharmaceutical ingredient, mechanism of action, and primary therapeutic indication are not widely documented in standard clinical pipeline registries.

Brand names: Bacto

Beyond the preview

Go deeper on Bacto.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacto.

Explore the full profile